Trevi Therapeutics, Inc. (TRVI) Social Stream



Trevi Therapeutics, Inc. (TRVI): $4.11

-0.16 (-3.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About TRVI

$TRVI This should not be sitting at this price.

$3B+ est. PN global category in
$20B pruritus market
PRISM: Ph2b/3 study of pruritus in
PN enrollment expected to be
completed in 2H 2021 with top-line
data 1H2022
• Fast Track designation granted for
moderate to severe pruritus in PN

$4B est. IPF global category in $10B
chronic cough market
CANAL: Ph2 study of chronic cough
in IPF has restarted enrollment
post-covid, with top-line data
expected 1H2022
Bobbie_Who, published July 30, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3215 seconds.